Acquired HER2 mutations in ER+ metastatic breast cancer confer resistance to estrogen receptor–directed therapies

Authors: Utthara Nayar, Ofir Cohen, Christian Kapstad, Michael S. Cuoco, Adrienne G. Waks, Seth A. Wander, Corrie Painter, Samuel S. Freeman, Nicole S. Persky, Lori Marini, Karla Helvie, Nelly Oliver, Orit Rozenblatt–Rosen, X. Cynthia, Aviv Regev, Eric P. Winer, Nancy U. Lin, Nikhil Wagle - Nature Genetics 2018 cited by 239